What is the recommended starting dose and titration schedule for ramipril in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ramipril Dosing

For hypertension, start ramipril at 2.5 mg once daily and titrate to a usual maintenance range of 2.5-20 mg daily (given once daily or divided twice daily), with most patients controlled on 2.5-10 mg daily 1.

Starting Doses by Indication

Hypertension

  • Standard patients: 2.5 mg once daily 1
  • Renal impairment (CrCl <40 mL/min): 1.25 mg once daily 1
  • Volume depletion or suspected renal artery stenosis: 1.25 mg once daily 1

Heart Failure Post-Myocardial Infarction

  • Standard starting dose: 2.5 mg twice daily (5 mg total daily) 1
  • If hypotensive: Switch to 1.25 mg twice daily 1
  • With renal impairment: 1.25 mg once daily initially 1

Titration Strategy

Hypertension Titration

  • Adjust dose based on blood pressure response 1
  • Target maintenance: 2.5-20 mg daily 2, 1
  • If antihypertensive effect diminishes toward end of dosing interval, consider increasing dose or switching to twice-daily administration 1
  • Add a diuretic if blood pressure remains uncontrolled on ramipril alone 1

Heart Failure Post-MI Titration

  • Target dose: 5 mg twice daily (10 mg total daily) 3, 1
  • Increase dose after one week at starting dose (if tolerated) 1
  • Space dosage increases approximately 3 weeks apart 1
  • Guideline-directed dosing: Titrate to target doses shown efficacious in randomized controlled trials to reduce cardiovascular mortality and heart failure hospitalizations 3
  • Titration can occur as frequently as every 1-2 weeks depending on symptoms, vital signs, and laboratory findings 3

Critical Monitoring Points

First Dose Precautions

  • Observe patient under medical supervision for at least 2 hours after initial dose 1
  • Continue observation until blood pressure stabilizes for an additional hour 1
  • Consider reducing concomitant diuretic dose to minimize hypotension risk 1
  • Hypotension after first dose does not preclude careful subsequent titration 1

Renal Function Considerations

  • Establish baseline renal function before initiating therapy 1
  • In patients with CrCl <40 mL/min, 25% of usual dose produces full therapeutic ramiprilat levels 1
  • Maximum dose with renal impairment:
    • Hypertension: 5 mg daily 1
    • Heart failure post-MI: 2.5 mg twice daily 1

Common Pitfalls to Avoid

Dry cough is the most common adverse effect, occurring in approximately 13-22% of patients 4, 5. This is 8 times more frequent than with ARBs 6. If intolerable, switching to an ARB (like losartan) is safe and effective 6.

Avoid combining ramipril with ARBs or direct renin inhibitors—this combination is potentially harmful and not recommended 2.

Hyperkalemia risk increases with concomitant use of potassium supplements, potassium salt substitutes, or potassium-sparing diuretics 2, 1.

Angioedema history with ACE inhibitors is an absolute contraindication 2. Patients with prior ACE inhibitor angioedema can receive an ARB only after waiting 6 weeks following ACE inhibitor discontinuation 2.

Administration Options

Ramipril capsules should generally be swallowed whole, but can be opened and contents either:

  • Sprinkled on approximately 4 oz of applesauce, or
  • Mixed in 4 oz (120 mL) of water or apple juice 1

These mixtures can be prepared up to 24 hours in advance (room temperature) or 48 hours (refrigerated) 1.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.